Biomea Fusion BMEA
NASDAQ BMEA
$1.37 +0.01 (+0.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Operating Expenses (2020 - 2026)

Biomea Fusion (BMEA) posted Operating Expenses of $12.8 million for Q1 2026, up 9.0% sequentially from $11.7 million in Q4 2025, and down 57.01% YoY from $29.7 million in Q1 2025.

Biomea Fusion (BMEA) Operating Expenses (2020 - 2026) Analysis & Trends

Biomea Fusion has reported Operating Expenses for 7 years, with the latest figure at $12.8 million in Q1 2026.

  • Quarterly Operating Expenses fell 57.01% year-over-year to $12.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $66.6 million (down 49.84% YoY) and the FY2025 annual result came in at $83.5 million, down 42.03% from the prior year.
  • Operating Expenses improved to $12.8 million in Q1 2026 per BMEA's latest filing, from $11.7 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $41.1 million in Q1 2024 and troughed at $11.7 million in Q4 2025.
  • A 5-year average of $26.5 million and a median of $27.7 million in 2023 frame the typical range for Operating Expenses.
  • The sharpest annual moves came in 2022 and 2025: Operating Expenses soared 180.01% in 2022, then plunged 61.03% in 2025.
  • Over 5 years, Operating Expenses stood at $26.3 million in 2022, then surged by 42.06% to $37.3 million in 2023, then slipped by 19.43% to $30.1 million in 2024, then slumped by 61.03% to $11.7 million in 2025, then climbed by 9.0% to $12.8 million in 2026.
  • According to Business Quant data, Operating Expenses over the past three periods registered $12.8 million, $11.7 million, and $20.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 2.09 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 3.00 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 2.89 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 960.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.21 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.06 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -784.57 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 427.03 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 541.02 Mn
10 Biomea Fusion 97.69 Mn 97.69 Mn - 12.77 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 12.77 Mn
Mar 31, 2026 12.77 Mn
Dec 31, 2025 11.72 Mn
Sep 30, 2025 20.81 Mn
Jun 30, 2025 21.28 Mn
Mar 31, 2025 29.71 Mn
Dec 31, 2024 30.07 Mn
Sep 30, 2024 34.04 Mn
Jun 30, 2024 38.90 Mn
Mar 31, 2024 41.06 Mn
Dec 31, 2023 37.33 Mn
Sep 30, 2023 31.12 Mn
Jun 30, 2023 27.66 Mn
Mar 31, 2023 30.03 Mn
Dec 31, 2022 26.28 Mn
Sep 30, 2022 23.48 Mn
Jun 30, 2022 17.47 Mn
Mar 31, 2022 16.40 Mn
Dec 31, 2021 14.74 Mn
Sep 30, 2021 12.64 Mn